Introduction
Subjects and methods
Patients
Determination of eNOS genotype
Statistical analysis
Results
Total (n = 68) | Idiopathic (n = 45) | Secondary (n = 23) | |
---|---|---|---|
Gender (M/F) | 56/12 (82.35 %/17.65 %) | 38/7 (84.44 %/15.56 %) | 18/5 (78.26 %/21.74 %) |
Age (years) | 44.98 (15–77) | 44.42 (15–77) | 46.08 (20–74) |
Smoking | 27 (39.7 %) | 21 (46.66 %) | 6 (26.06 %) |
Diabetes mellitus | 8 (11.76 %) | 4 (8.88 %) | 4 (17.39 %) |
Coronary disease | 3 (4.41 %) | 2 (4.44 %) | 1 (4.34 %) |
Thrombosis | 1 (1.47 %) | 0 | 1 (4.34 %) |
Leriche syndrome | 1 (1.47 %) | 1 (2.22 %) | 0 |
Hypertension | 13 (19.11 %) | 8 (17.77 %) | 5 (21.73 %) |
Hyperlipidaemia | 1 (1.47 %) | 1 (2.22 %) | 0 |
Patients | ||||
---|---|---|---|---|
Control (n = 200) | Total (n = 136) | Idiopathic (n = 90) | Secondary (n = 46) | |
4a | 18 (9 %) | 31 (22.79 %)a
| 18 (20 %)b
| 13 (28.26 %)c
|
4b | 182 (91 %) | 105 (77.21 %) | 72 (80 %) | 33 (71.74 %) |
Patients | ||||
---|---|---|---|---|
Control (n = 100) | Total (n = 68) | Idiopathic (n = 45) | Secondary (n = 23) | |
4a/a | 1 (1 %) | 3 (4.41 %) | 1 (2.22 %) | 2 (8.70 %)a
|
4a/b | 16 (16 %) | 25 (36.76 %)b
| 16 (35.56 %)c
| 9 (39.13 %)d
|
4b/b | 83 (83 %) | 40 (58.82 %) | 28 (62.22 %) | 12 (52.17 %) |